2018 annual financial data
Silence Therapeutics 2018 Operating margin
Silence Therapeutics 2018 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -20,571,000 GBP and net income was -18,411,000 GBP.
Operating cash flow was -16,760,000 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 GBP
- Operating income
- -20,571,000 GBP
- Net income
- -18,411,000 GBP
- Operating cash flow
- -16,760,000 GBP